Geneseeq
Nanjing, CN · 2 known investors
Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.
AI & Machine LearningBiotechDigital Health
Investors · 2
Frequently asked questions
- What does Geneseeq do?
- Geneseeq develops next-generation sequencing (NGS) based genetic tests and in-vitro diagnostic products for cancer patients, using gene profiling to guide targeted drug selection, indicate drug resistance mechanisms, and monitor post-surgical recurrence. It also works on early cancer screening and provides molecular diagnostic services and pharmaceutical partnership/companion diagnostics for precision oncology.
- Who are Geneseeq's investors?
- Geneseeq's investors include LAV, Lilly Asia Ventures.
- Where is Geneseeq headquartered?
- Geneseeq is headquartered in Nanjing, CN.